¥20.33 ($3.03)

+0.51 (+2.57%)

SHZ · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 37 · ¥10.6B mcap · 263M float · 4.21% daily turnover

Revenue

$925M +9.1% ▲

5Y CAGR: +7.7%

Gross Profit

$881M +9.0% ▲

5Y CAGR: +7.4%

Operating Income

$369M +7.0% ▲

5Y CAGR: +1.5%

Net Income

$318M +2.5% ▲

5Y CAGR: +1.3%

EPS (Diluted)

$0.61 +3.4% ▲

5Y CAGR: +1.4%

EBITDA

$361M +6.6% ▲

5Y CAGR: +2.0%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$636M	$808M	$896M	$848M	$925M
YoY Growth	-0.5%	+27.0%	+10.9%	-5.3%	+9.1%
Cost of Revenue	$29M	$34M	$43M	$40M	$45M
Gross Profit	$608M	$773M	$854M	$808M	$881M
Gross Margin	95.5%	95.7%	95.3%	95.3%	95.2%
R&D Expenses	$65M	$88M	$106M	$112M	$120M
SG&A Expenses	$258M	$334M	$360M	$385M	$435M
Operating Expenses	$286M	$380M	$457M	$463M	$511M
Operating Income	$322M	$393M	$396M	$345M	$369M
Operating Margin	50.5%	48.6%	44.2%	40.7%	39.9%
Interest Expense	$100K	$487K	$444K	$1M	$1M
Income Before Tax	$323M	$393M	$399M	$346M	$365M
Tax Expense	$53M	$67M	$63M	$50M	$61M
Net Income	$278M	$338M	$349M	$310M	$318M
Net Margin	43.8%	41.8%	38.9%	36.6%	34.3%
EPS (Diluted)	$0.53	$0.65	$0.67	$0.59	$0.61
EBITDA	$295M	$366M	$402M	$338M	$361M
Shares Outstanding	524M	524M	524M	524M	524M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$301M	$195M	$228M	$256M	$369M	$209M	$253M	$261M
Cost of Revenue	$13M	$10M	$12M	$12M	$16M	$11M	$12M	$26M
Gross Profit	$288M	$185M	$217M	$244M	$353M	$198M	$241M	$235M
Gross Margin	95.7%	94.8%	94.8%	95.4%	95.7%	94.7%	95.2%	90.0%
R&D Expenses	$29M	$32M	$30M	$29M	$27M	$31M	$25M	$17M
SG&A Expenses	$126M	$111M	$109M	$107M	$138M	-$110M	$117M	$109M
Operating Expenses	$144M	$132M	$132M	$127M	$167M	$157M	$139M	$130M
Operating Income	$144M	$53M	$85M	$117M	$187M	$41M	$101M	$105M
Operating Margin	47.8%	27.1%	37.1%	45.6%	50.6%	19.5%	40.1%	40.1%
Interest Expense	$280K	$165K	$220K	$187K	$190K	$196K	$233K	$172K
Income Before Tax	$143M	$52M	$84M	$116M	$195M	$38M	$132M	$109M
Tax Expense	$23M	$10M	$12M	$17M	$30M	$6M	$15M	$17M
Net Income	$123M	$46M	$74M	$103M	$168M	$36M	$119M	$94M
Net Margin	40.9%	23.3%	32.5%	40.1%	45.5%	17.3%	47.2%	36.1%
EPS (Diluted)	$0.23	$0.09	$0.14	$0.20	$0.32	$0.07	$0.23	$0.18
EBITDA	$137M	$52M	$87M	$116M	$195M	$54M	$132M	$120M
Shares Outstanding	524M	524M	524M	524M	524M	524M	524M	524M

300357.SZ SHZ